Greenspring Associates
Greenspring Associates is a platform focused on fund, direct, and secondary investments within the venture capital asset class.
Business Model:
Revenue: $11.9M
Employees: 51-200
Rankings
Detailed Greenspring Associates Information
Greenspring Associates was acquired by
StepStone Group.
The acquisition happend on 2021-07-07.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 100 Painters Mill Road
City: Owings Mills
State: MD
Zip: 21117
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$3B
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Greenspring Associates is a global investment firm that provides commingled funds and customized partnership capabilities to a diverse group of institutions and individuals in North America, Europe, Asia, the Middle East, and Australia. Through a synergistic platform, the firm invests in established and emerging venture capital fund managers, in early and growth stage venture-backed companies and in secondary venture capital fund and secondary direct investments. Currently managing over $7.3 billion of committed capital, its dedicated investment team combines broad venture fund and direct investment expertise.
Contact Phone:
+14103632725
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 10/2017 | Docker | Series E | 91.9M |
| 6/2015 | Namely | Series C | 45M |
| 6/2017 | Xometry | Series B | 15M |
| 5/2019 | Xometry | Series D | 50M |
| 2/2013 | TriVascular | Debt Financing | 96M |
| 4/2014 | WalkMe | Series D | - |
| 11/2018 | Bright Health Group | Series C | 200M |
| 11/2014 | Gigya | Series F | 35M |
| 11/2003 | Recruitmax | Series A | 17.2M |
| 1/2005 | BlueArc | Series E | 15M |
| 2/2017 | Cologix | Private Equity Round | - |
| 3/2015 | Namely | Venture Round | 11M |
| 7/2019 | Socio | Series A | 6M |
| 2/2016 | Namely | Venture Round | 30M |
| 5/2019 | Phathom Pharmaceuticals | Private Equity Round | 90M |
| 2/2021 | Electric | Series C | 40M |
| 11/2018 | Rocket Lab | Series E | 140M |
| 11/2018 | Rocket Lab | Series E | 140M |
| 4/2016 | The RealReal | Series E | 40M |
| 8/2011 | zulily | Series C | 43M |
| 8/2010 | G5 | Venture Round | 15M |
| 7/2019 | TurnKey Vacation Rentals | Series E | 48M |
| 1/2016 | Valiant | Series A | - |
| 10/2021 | Electric | Series D | 90M |
| 5/2016 | Assent Inc. | Series A | 20M |
| 1/2021 | Delivery Hero | Post-IPO Secondary | 0 |
| 5/2008 | Entellus Medical | Series C | 15M |
| 5/2019 | Crown Laboratories | Private Equity Round | - |
| 3/2020 | Hi Marley | Series A | 8M |
| 7/2014 | Matrix Medical Network | Series A | - |
| 5/2019 | Logz.io | Series D | 52M |
| 6/2021 | Yieldstreet | Series C | 0 |
| 10/2014 | Demandbase | Series E | 15M |
| 6/2015 | WalkMe | Series D | 25M |
| 3/2021 | Hi Marley | Series B | 25M |
| 10/2012 | Workfront | Growth | 17M |
| 9/2020 | Salsify | Series E | 155M |
| 1/2012 | Lithium Technologies | Series D | 53.4M |
| 9/2011 | Grubhub | Series E | 50M |
| 6/2005 | Verus Pharmaceuticals | Series A | 0 |
| 3/2020 | UserTesting | Series F | 100M |
| 7/2011 | Cvent | Venture Round | 136M |
| 9/2012 | UserTesting | Series B | 3M |
| 10/2016 | Oblong Industries | Series D | 35M |
| 7/2010 | Tethys BioScience | Venture Round | 0 |
| 11/2007 | Zonare Medical Systems | Series G | 30M |
| 7/2010 | BARRX Medical | Series D | 15M |
| 5/2021 | Dooly | Series B | 80M |
| 11/2003 | Vurv Technology | Series A | 17.2M |
| 1/2004 | ChannelAdvisor | Series B | 7M |
| 6/2021 | Lev | Series A | 0 |
| 7/2021 | La Haus | Debt Financing | 50M |
| 4/2016 | Woowa Bros | Series E | - |
| 6/2012 | Sonos | Series F | 135M |
| 10/2012 | Bravo Health | Series A | - |
| 10/2021 | Scout Bio | Series B | 0 |
| 10/2014 | DocuSign | Series E | 0 |
| 4/2017 | Endologix | Post-IPO Debt | 170M |
| 8/2018 | Everside Health | Growth | 165M |
| 4/2019 | Branch International | Series C | 0 |
| 2/2019 | Yieldstreet | Series B | 62M |
| 12/2013 | Cloudflare | Series C | 50M |
| 8/2015 | Ocera Therapeutics | Post-IPO Debt | 20M |
| 7/2007 | GlassHouse Technologies | Series E | 7.5M |
| 1/2019 | Outdoorsy | Series C | 0 |
| 1/2019 | Workrise | Series C | 0 |
| 8/2007 | Zayo | Private Equity Round | 225M |
| 2/2008 | Ocera Therapeutics | Series C | 0 |
| 9/2021 | Panorays | Series B | 0 |
| 3/2023 | Panorays | Series C | - |
| 2/2014 | Workfront | Series D | 38M |
| 8/2003 | Myogen | Series D | 40M |
| 2/2021 | Omnispace | Private Equity Round | 0 |
| 5/2021 | Pipe | Venture Round | 0 |
| 12/2015 | JW Player | Series D | 20M |
| 9/2010 | EVERFI | Series A | 11M |
| 1/2021 | La Haus | Series B | 0 |
| 3/2015 | Stonepeak Infrastructure Partners | Series A | - |
| 1/2014 | Trine Pharmaceuticals | Series A | - |
| 9/2020 | Xometry | Series E | 75M |
| 8/2011 | Entellus Medical | Series E | 0 |
| 3/2019 | Stash Financial | Series E | 73M |
| 9/2021 | Ribbon Home | Series C | 0 |
| 3/2019 | Glossier | Series D | 100M |
| 1/2016 | Data.ai | Series E | 63M |
| 11/2018 | LPA Lucht Probst Associates | Private Equity Round | - |
| 6/2004 | Paracor Medical | Series C | 30.5M |
| 11/2012 | Medialets | Series C | 10M |
| 3/2019 | The RealReal | Series H | 70M |
| 1/2014 | Kareo | Series F | 29.5M |
| 11/2021 | Jackpocket | Series D | 120M |
| 11/2016 | Infrastructure Leasing &a; Financial Services Limited | Debt Financing | 49.9M |
| 5/2018 | Rover | Series G | 125M |
| 7/2017 | Assent Inc. | Series B | 31.6M |
| 4/2002 | IntraLuminal Therapeutics | Venture Round | 20M |
| 5/2010 | Intarcia Therapeutics | Venture Round | 14.5M |
| 3/2020 | Kallyope | Series C | 112M |
| 3/2019 | Scout Bio | Series B | 20M |
| 11/2020 | Imago BioSciences | Series C | 80M |
| 3/2019 | Imago BioSciences | Series B | 40M |
| 8/2020 | Aetion | Series B | 19M |
| 12/2020 | EverlyWell | Series D | 175M |
| 6/2021 | Recycle Track Systems | Series C | 35M |
| 3/2020 | Kyash | Series C | 43.3M |
| 7/2019 | MoneyLion | Series C | 100M |
| 9/2021 | MetaCX | Venture Round | 7M |
| 5/2020 | Aqua Security | Series D | 30M |
| 9/2014 | Teladoc Health | Equity | 50.3M |
| 5/2011 | Cameron Health | Series F | 107M |
| 12/2020 | LogicGate | Venture Round | 8.8M |
| 3/2006 | Proofpoint | Series E | 0 |
| 6/2017 | Scopely | Series C | 60M |
| 9/2019 | Tipalti | Series D | 0 |
| 10/2014 | SolidFire | Series D | 82M |
| 4/2016 | Woowa Bros | Series E | 50M |
| 7/2021 | LogicGate | Series C | 113M |
| 8/2015 | Workfront | Series E | 0 |
| 12/2011 | IntegenX | Series C | 40M |
| 12/2012 | Cloud Sherpas | Series C | 40M |
| 3/2016 | Cyara | Series A | 25M |
| 3/2021 | Yugabyte | Series B | 48M |
| 4/2014 | Chewy | Series B | 30M |
| 12/2020 | Epirus | Series B | 70M |
| 4/2015 | Green Chef | Series A | 15.5M |
| 11/2021 | Trusted Health | Series C | 94M |
| 5/2017 | Demandbase | Series H | 0 |
| 3/2006 | Neotract | Venture Round | 21.4M |
| 8/2006 | Esprit Pharma | Series B | 90.8M |
| 6/2014 | Senseonics | Venture Round | 0 |
| 8/2007 | DBS Communications | Series D | 17.2M |
| 6/2017 | Bright Health Group | Series B | 160M |
| 8/2014 | Chewy | Series C | 0 |
| 4/2020 | Stash Financial | Series F | 0 |
| 1/2016 | JW Player | Series D | 20.1M |
| 8/2015 | Everything But The House | Series B | 0 |
| 10/2021 | Turing.com | Series D | 0 |
| 6/2021 | Outdoorsy | Series D | 0 |
| 2/2019 | Ceros | Series C | 0 |
| 12/2019 | LogicGate | Series B | 24.8M |
| 10/2014 | Kareo | Debt Financing | 15M |
| 3/2015 | NGM Biopharmaceuticals | Series E | 106M |
| 1/2018 | MoneyLion | Series B | 42M |
| 5/2019 | Health IQ | Series D | 55M |
| 11/2020 | Inspectiv | Seed Round | 6M |
| 3/2012 | Exinda | Series B | 12M |
| 6/2021 | Blockdaemon | Series A | 0 |
| 6/2018 | Scopely | Series C | 100M |
| 5/2016 | Everlane | Series D | - |
| 3/2021 | Entrada Therapeutics | Series B | 0 |
| 1/2017 | Namely | Series D | 50M |
| 1/2011 | TMON | Venture Round | 8.1M |
| 8/2018 | Salsify | Series D | 43M |
| 7/2018 | The RealReal | Series G | 115M |
| 2/2021 | Aviatrix | Series D | 0 |
| 5/2016 | WalkMe | Series E | 50M |
| 8/2018 | RealSelf | Series C | - |
| 10/2013 | Alibaba Group | Secondary Market | - |
| 3/2015 | Rocket Lab | Series B | - |
| 5/2021 | Immuta | Series D | 90M |
| 9/2020 | Bright Health Group | Series E | 500M |
| 1/2011 | Turn | Series D | 20M |
| 9/2021 | Aviatrix | Series E | 0 |
| 7/2007 | newScale | Series D | 0 |
| 6/2017 | Omnispace | Series A | 30M |
| 4/2001 | Xcel Pharmaceuticals | Venture Round | 70M |
| 4/2018 | OPĀQ | Series B | 22.5M |
| 8/2018 | Everside Health | Private Equity Round | 165M |
| 9/2013 | Gigya | Series E | 25M |
| 9/2017 | MapR Technologies | Venture Round | 56M |
| 4/2005 | Orexigen Therapeutics | Series B | 35M |
| 12/2009 | Lithium Technologies | Series C | 27.3M |
| 4/2007 | GenVault | Venture Round | 18M |
| 6/2000 | TargetRx | Series B | 12M |
| 12/2008 | Roundbox | Series C | 20M |
| 6/2010 | Mavenir | Series D | 13.6M |
| 2/2013 | Khoros | Series C | 18M |
| 9/2019 | Grove Collaborative | Series D | 0 |
| 4/2019 | Intrinsic Therapeutics | Series E | 52M |
| 1/2014 | Nutanix | Series D | 101M |
| 7/2004 | SkinMedica | Series D | 30M |
| 4/2006 | SkinMedica | Series E | 0 |
| 10/2002 | Pharmion | Venture Round | 40M |
| 12/2019 | Bright Health Group | Series D | 0 |
| 12/2007 | Forhealth Technologies | Venture Round | 9M |
| 5/2011 | Mavenir | Series E | 40M |
| 10/2016 | Everything But The House | Series C | 0 |
| 2/2020 | Veev | Series B | 85M |
| 9/2015 | Cloudflare | Series D | 110M |
| 2/2021 | Jackpocket | Series C | 0 |
| 3/2005 | newScale | Series C | 0 |
| 8/2002 | Proxima Therapeutics | Series E | 14M |
| 10/2019 | Tenaya Therapeutics | Series B | 92M |
| 5/2020 | Doma | Series C | 0 |
| 7/2015 | Demandbase | Series G | 30M |
| 3/2009 | ScanSafe | Series C | 13.5M |
| 4/2020 | Cohesity | Series E | 250M |
| 2/2017 | Fuze, an 8x8 company | Series E | 104M |
| 7/2021 | Vestwell | Series C | 0 |
| 7/2011 | Photobox | Private Equity Round | 0 |
| 4/2011 | ExactTarget | Private Equity Round | 30M |
| 5/2021 | CircleCI | Series F | 100M |
| 1/2019 | OneLogin | Series D | 100M |
| 9/2021 | Blockdaemon | Series B | 0 |
| 7/2006 | Digital Chocolate | Series C | 22.5M |
| 1/2008 | Tethys BioScience | Series C | - |
| 9/2021 | HilleVax | Equity | 135M |
| 10/2011 | Kareo | Series D | 10M |
| 7/2015 | Kareo | Series G | 55.4M |
| 11/2012 | Intronis | Venture Round | 12M |
| 9/2021 | Mammoth Biosciences | Series D | 0 |
| 3/2006 | Inteliquent | Series C | 12M |
| 9/2014 | Intrinsic Therapeutics | Venture Round | 17.3M |
| 8/2018 | Quibi | Venture Round | 0 |
| 8/2014 | PCI Pharma Services | Seed Round | - |
| 3/2010 | Akorri Networks | Series E | 10.1M |
| 3/2015 | euNetworks Group | Post-IPO Equity | - |
| 11/2002 | Sabrix | Series B | 6.2M |
| 1/2016 | Ticket Monster | Series A | - |
| 3/2021 | Aqua Security | Series E | 135M |
| 6/2021 | Bowery Valuation | Series B | 35M |
| 7/2017 | Colorescience | Series C | 15M |
| 10/2012 | Concentric Medical | Series A | - |
| 11/2021 | Trusted Health | Series C | 0 |
| 11/2021 | Jackpocket | Series D | 0 |
| 10/2021 | Scout Bio | Series B | 0 |
| 10/2021 | Electric | Series D | 0 |
| 10/2021 | Turing.com | Series D | 0 |
| 9/2021 | MetaCX | Venture Round | 0 |
| 9/2021 | Panorays | Series B | 0 |
| 9/2021 | Blockdaemon | Series B | 0 |
| 9/2021 | Ribbon Home | Series C | 0 |
| 9/2021 | Mammoth Biosciences | Series D | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
